
|Articles|August 18, 2021
Pharmacy Clinical Pearl of the Day: Non-alcoholic Steatohepatitis
Author(s)Saro Arakelians, PharmD
Non-alcoholic steatohepatitis is the most severe form of non-alcoholic fatty liver disease.
Advertisement
Clinical Pearl of the Day: Non-alcoholic steatohepatitis (NASH)
NASH is defined as the liver manifestation of a metabolic disorder and is the most severe form of non-alcoholic fatty liver disease (NAFLD).
Explanation:
- NAFLD is a condition in which fat builds up in the liver.
- Nonalcoholic fatty liver (NAFL) and NASH are types of NAFLD.
- Patients with NASH, develop inflammation and liver damage, along with fat in the liver.
- Physicians use patients’ medical history, a physical exam, and tests to diagnose NAFLD.
- They can also use blood tests, imaging tests, and liver biopsy to diagnose NAFLD and tell the difference between NAFL or NASH.
Reference
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
SABCS 2025 Roundup: Advancing Therapy and Precision Care in Breast Cancer
2
2025 FDA Approvals Highlight the Growing Role of Biomarkers in Breast Cancer
3
Pharmacist Spotlight: Kelly Gable, PharmD, BCPP, FAAPP
4
Ribociclib Plus Fulvestrant Shows Strong PFS and OS Benefits in Patients With Invasive Lobular Carcinoma
5

















































































































































































































